StockData
Evaxion A/S logo

Evaxion A/S (EVAX) income statement

EVAXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 5, 2026Score 2/30
$2.25+0.22 (+10.84%)

Close on Nov 20, 2026Market cap $18.77MP/E –Yield –

See a number that looks wrong?